“ «SGLT2 INHIBITORS: RATIONALE FOR THE USE IN HEART FAILURE», RESOLUTION ON THE RESULTS OF THE PANEL OF EXPERTS WITH INTERNATIONAL PARTICIPATION, ALMATY” (2022) Interdisciplinary Approaches to Medicine, 3(2), pp. 38–42. doi:10.26577/IAM.2022.v3.i2.08.